Werkgroep Cardiologische centra Nederland English

BEST (Follow up)

A double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events
Middel
bexagliflozin
Populatie
diabetes mellitus
Fase
III
Jaar aanvang
2015
Meer informatie
ClinivalTrials.gov

Studiedirecteur

dr. A.F.M. Kuijper (Cardioloog)
Haarlem, Spaarne Gasthuis